Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth CorpfiledCriticalWyeth Corp
Publication of PA8626601A1publicationCriticalpatent/PA8626601A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
ESTA INVENCION SE REFIERE, POR EJEMPLO, A NUEVAS FORMULACIONES Y METODOS PARA LA LIBERACION DE 4-CIANO-N{(2R)-2-[4-(2,3-DIHIDRO-BENZO[1,4]DIOXIN-5IL]-PIPERAZIN-1-IL]-PROPIL]-N-PIRIDIN]-2-IL-BENZAMIDA, SALES FARMACEUTICAMENTE Y/O METABOLITOS; ASI COMO AL USO DE ESTAS FORMULACIONES Y METODOS PARA TRATAR ENFERMEDADES.THIS INVENTION REFERS, FOR EXAMPLE, TO NEW FORMULATIONS AND METHODS FOR THE RELEASE OF 4-CIANO-N {(2R) -2- [4- (2,3-DIHIDRO-BENZO [1,4] DIOXIN-5IL] - PIPERAZIN-1-IL] -PROPIL] -N-PIRIDIN] -2-IL-BENZAMIDA, PHARMACEUTICALLY SALTS AND / OR METABOLITES; AS WELL AS THE USE OF THESE FORMULATIONS AND METHODS TO TREAT DISEASES.
PA8626601A2004-03-192005-03-18
DOSAGE FORMS AND PHARMACEUTICAL COMPOSITIONS
PA8626601A1
(en)
SUBSTITUTED HETEROARILY DERIVATIVE COMPOUNDS; METHOD FOR THE PREPARATION OF COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, DEPRESSION, ALZHEIMER'S DISEASE AND HYPERTENSION BETWEEN OTHERS.
Compounds derived from 4,5-dihydro-oxazol-2-ylamine; preparation procedure; pharmaceutical composition; and its use for the treatment of Alzheimer's disease.
Compounds derived from imidazopyrimidine, substituted, pde10a inhibitors; preparation procedure; pharmaceutical composition; and its use for the treatment or prevention of psychotic disorders, schizophrenia, parkinson's disease, multiple sclerosis, among others.
COMPOUNDS DERIVED FROM N- (1-FTALAZIN-1-IL-PIPERIDIN-4-IL) -AMIDAS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT AND PREVENTION OF FERTILITY, OSTEOPOROSIS AND CANCER DISORDERS.
COMPOUNDS DERIVED FROM SIPROCICLIC AZAINDOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF PAIN, CONDITIONS OF PANIC, DEPRESSION, EVIL OF ALZHEIMER, MIGRANA, AMONG OTHERS.
Crystalline form e3 of atazanavir bisulfate; pharmaceutical composition comprising it; Useful for the treatment of diseases caused by retroviruses (divisional of the application 1057-05).